Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and [...] (Q28818062)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and [...] |
scientific article (publication date: 2013) |
Statements
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action (English)
Marcella Reale
1 reference
Qian-Sheng Yu
Harold W Holloway
Weiming Luo
Balmiki Ray
Debomoy K Lahiri
Jack T Rogers
Nigel H Greig
1 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference